Legend Biotech Corporation (LEGN)
USD 33.17
(-2.33%)
USD 33.17
(-2.33%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 583.14 Million USD | 10.4% |
| 2022 | 509.69 Million USD | 10.13% |
| 2021 | 462.82 Million USD | 51.81% |
| 2020 | 304.87 Million USD | 58.27% |
| 2019 | 192.63 Million USD | 200.03% |
| 2018 | 64.2 Million USD | 569.08% |
| 2017 | 9.59 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 151.39 Million USD | -6.96% |
| 2024 Q2 | 172.67 Million USD | 17.6% |
| 2023 Q4 | 162.71 Million USD | 12.31% |
| 2023 FY | 562.69 Million USD | 10.4% |
| 2023 Q3 | 144.88 Million USD | 0.88% |
| 2023 Q2 | 143.62 Million USD | 14.85% |
| 2023 Q1 | 125.04 Million USD | -5.19% |
| 2022 Q4 | 131.89 Million USD | -9.38% |
| 2022 Q3 | 145.54 Million USD | 27.32% |
| 2022 Q2 | 114.31 Million USD | -0.42% |
| 2022 Q1 | 114.8 Million USD | -26.62% |
| 2022 FY | 509.69 Million USD | 10.13% |
| 2021 FY | 462.82 Million USD | 51.81% |
| 2021 Q4 | 156.45 Million USD | 51.17% |
| 2021 Q3 | 103.49 Million USD | -4.32% |
| 2021 Q1 | 93.23 Million USD | -7.04% |
| 2021 Q2 | 108.16 Million USD | 16.02% |
| 2020 Q2 | 67.63 Million USD | 18.93% |
| 2020 FY | 304.87 Million USD | 58.27% |
| 2020 Q4 | 100.28 Million USD | 26.98% |
| 2020 Q3 | 78.98 Million USD | 16.78% |
| 2020 Q1 | 56.86 Million USD | -28.77% |
| 2019 Q4 | 79.83 Million USD | 65.06% |
| 2019 Q2 | 39.27 Million USD | 56.91% |
| 2019 Q1 | 25.03 Million USD | 0.0% |
| 2019 FY | 192.63 Million USD | 200.03% |
| 2019 Q3 | 48.36 Million USD | 23.15% |
| 2018 FY | 64.2 Million USD | 569.08% |
| 2017 FY | 9.59 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Sangamo Therapeutics, Inc. | 228.68 Million USD | -155.005% |
| IDEAYA Biosciences, Inc. | 157.81 Million USD | -269.514% |
| Eton Pharmaceuticals, Inc. | 22.25 Million USD | -2520.523% |
| Autolus Therapeutics plc | 196.72 Million USD | -196.425% |
| Greenwich LifeSciences, Inc. | 9.32 Million USD | -6151.644% |
| Enlivex Therapeutics Ltd. | 29.39 Million USD | -1883.824% |
| Shattuck Labs, Inc. | 93.61 Million USD | -522.925% |
| LENZ Therapeutics, Inc. | 70.7 Million USD | -724.781% |
| CervoMed Inc. | 14.95 Million USD | -3798.61% |
| Rocket Pharmaceuticals, Inc. | 259.65 Million USD | -124.581% |
| Corbus Pharmaceuticals Holdings, Inc. | 13.9 Million USD | -4092.38% |
| Aptose Biosciences Inc. | 52.35 Million USD | -1013.807% |
| Precision BioSciences, Inc. | 92.46 Million USD | -530.679% |
| Dyadic International, Inc. | 9.15 Million USD | -6271.292% |
| TScan Therapeutics, Inc. | 114.5 Million USD | -409.266% |
| Intensity Therapeutics, Inc. | 8.31 Million USD | -6909.797% |
| Nektar Therapeutics | 190.9 Million USD | -205.467% |
| CytomX Therapeutics, Inc. | 107.69 Million USD | -441.463% |
| VYNE Therapeutics Inc. | 29.68 Million USD | -1864.642% |
| EyePoint Pharmaceuticals, Inc. | 116.45 Million USD | -400.756% |
| Leap Therapeutics, Inc. | 87.04 Million USD | -569.966% |
| Adaptive Biotechnologies Corporation | 321.75 Million USD | -81.237% |
| GRI Bio, Inc. | 11.33 Million USD | -5046.911% |
| Xenetic Biosciences, Inc. | 7.05 Million USD | -8164.877% |
| Tenaya Therapeutics, Inc. | 131.19 Million USD | -344.494% |
| NeuroSense Therapeutics Ltd. | 10.28 Million USD | -5569.859% |
| Psyence Biomedical Ltd. | 2.75 Million USD | -21093.058% |
| IGM Biosciences, Inc. | 265.59 Million USD | -119.565% |
| INmune Bio, Inc. | 29.89 Million USD | -1850.579% |
| Opthea Limited | 191.96 Million USD | -203.773% |
| Milestone Pharmaceuticals Inc. | 62.09 Million USD | -839.072% |
| Omega Therapeutics, Inc. | 103.35 Million USD | -464.216% |
| Verastem, Inc. | 92.08 Million USD | -533.275% |
| Abeona Therapeutics Inc. | 17.93 Million USD | -3150.711% |
| Pliant Therapeutics, Inc. | 185.72 Million USD | -213.983% |
| Tonix Pharmaceuticals Holding Corp. | 121.4 Million USD | -380.322% |
| Ligand Pharmaceuticals Incorporated | 84.32 Million USD | -591.561% |
| NextCure, Inc. | 67.63 Million USD | -762.169% |
| Inhibikase Therapeutics, Inc. | 6.73 Million USD | -8562.357% |
| Organovo Holdings, Inc. | 14.91 Million USD | -3809.789% |
| Lixte Biotechnology Holdings, Inc. | 5.09 Million USD | -11356.149% |
| Arvinas, Inc. | 480 Million USD | -21.489% |
| Ovid Therapeutics Inc. | 59.67 Million USD | -877.232% |
| CASI Pharmaceuticals, Inc. | 47 Million USD | -1140.576% |
| Rani Therapeutics Holdings, Inc. | 66.09 Million USD | -782.23% |
| Centessa Pharmaceuticals plc | 178.13 Million USD | -227.359% |
| Arcturus Therapeutics Holdings Inc. | 245 Million USD | -138.014% |
| Syros Pharmaceuticals, Inc. | 30.77 Million USD | -1795.112% |
| Senti Biosciences, Inc. | 94.7 Million USD | -515.749% |
| BioRestorative Therapies, Inc. | 15.36 Million USD | -3694.893% |
| Apollomics, Inc. | 54.14 Million USD | -977.106% |
| PureTech Health plc | 144.59 Million USD | -303.29% |
| Oncternal Therapeutics, Inc. | 12.74 Million USD | -4475.122% |
| Barinthus Biotherapeutics plc | 84.71 Million USD | -588.353% |
| Kymera Therapeutics, Inc. | 244.12 Million USD | -138.874% |
| Synaptogenix, Inc. | 8.31 Million USD | -6914.136% |
| ChromaDex Corporation | 56.37 Million USD | -934.33% |
| Beam Therapeutics Inc. | 554.19 Million USD | -5.224% |
| Monopar Therapeutics Inc. | 8.83 Million USD | -6503.21% |
| Akebia Therapeutics, Inc. | 201.11 Million USD | -189.956% |
| Nurix Therapeutics, Inc. | 232.05 Million USD | -151.301% |
| Apellis Pharmaceuticals, Inc. | 855.2 Million USD | 31.812% |
| Dermata Therapeutics, Inc. | 8.04 Million USD | -7151.328% |
| Gritstone bio, Inc. | 148.37 Million USD | -293.024% |
| Mesoblast Limited | 5.9 Million USD | -9780.464% |
| Virpax Pharmaceuticals, Inc. | 15.68 Million USD | -3616.717% |
| Xeris Biopharma Holdings, Inc. | 168.43 Million USD | -246.212% |
| Fate Therapeutics, Inc. | 254.04 Million USD | -129.545% |
| MediWound Ltd. | 18.86 Million USD | -2990.656% |
| BioXcel Therapeutics, Inc. | 171.9 Million USD | -239.231% |
| Fortress Biotech, Inc. | 200.19 Million USD | -191.288% |
| Fractyl Health, Inc. Common Stock | 50.87 Million USD | -1046.141% |
| Achilles Therapeutics plc | 75.25 Million USD | -674.892% |
| Seres Therapeutics, Inc. | 234.3 Million USD | -148.88% |
| Checkpoint Therapeutics, Inc. | 52.25 Million USD | -1016.046% |
| Atossa Therapeutics, Inc. | 31.37 Million USD | -1758.511% |
| Zai Lab Limited | 547.47 Million USD | -6.515% |
| Fresh Tracks Therapeutics, Inc. | 14.36 Million USD | -3959.202% |
| Lyell Immunopharma, Inc. | 247.13 Million USD | -135.959% |
| Vanda Pharmaceuticals Inc. | 191.79 Million USD | -204.044% |
| Tarsus Pharmaceuticals, Inc. | 159.01 Million USD | -266.73% |
| InMed Pharmaceuticals Inc. | 9.01 Billion USD | 93.532% |
| FibroGen, Inc. | 398.11 Million USD | -46.477% |
| Celcuity Inc. | 66.23 Million USD | -780.48% |
| SeaStar Medical Holding Corporation | 14.21 Million USD | -4003.765% |
| ContextLogic Inc. | 387 Million USD | -50.683% |
| GH Research PLC | 41.22 Million USD | -1314.645% |
| HOOKIPA Pharma Inc. | 32.74 Million USD | -1680.813% |
| Cyclacel Pharmaceuticals, Inc. | 25.87 Million USD | -2153.875% |
| ImmuCell Corporation | 9.61 Million USD | -5963.461% |
| Amylyx Pharmaceuticals, Inc. | 316.54 Million USD | -84.223% |
| Amarin Corporation plc | 272.35 Million USD | -114.111% |
| TG Therapeutics, Inc. | 198.47 Million USD | -193.813% |
| Aptevo Therapeutics Inc. | 28.87 Million USD | -1919.34% |
| Jasper Therapeutics, Inc. | 68.86 Million USD | -746.844% |
| Foghorn Therapeutics Inc. | 142.06 Million USD | -310.489% |
| Y-mAbs Therapeutics, Inc. | 99.07 Million USD | -488.589% |
| Aptorum Group Limited | 10.56 Thousand USD | -5518970.604% |
| Ultragenyx Pharmaceutical Inc. | 958.24 Million USD | 39.145% |
| BioCryst Pharmaceuticals, Inc. | 430.64 Million USD | -35.414% |
| Chemomab Therapeutics Ltd. | 25.45 Million USD | -2190.526% |
| Arrowhead Pharmaceuticals, Inc. | 445.73 Million USD | -30.827% |
| TransCode Therapeutics, Inc. | 19.41 Million USD | -2903.036% |
| RAPT Therapeutics, Inc. | 127.06 Million USD | -358.945% |
| Ardelyx, Inc. | 169.93 Million USD | -243.154% |
| Ainos, Inc. | 12.95 Million USD | -4402.124% |
| Lyra Therapeutics, Inc. | 20.64 Million USD | -2724.083% |
| Prothena Corporation plc | 282.4 Million USD | -106.492% |
| HilleVax, Inc. | 133.34 Million USD | -337.32% |
| Adaptimmune Therapeutics plc | 200.02 Million USD | -191.54% |
| Celularity Inc. | 215.05 Million USD | -171.157% |
| Rallybio Corporation | 78.93 Million USD | -638.794% |
| Cue Biopharma, Inc. | 19.54 Million USD | -2884.06% |
| Omeros Corporation | 94.75 Million USD | -515.45% |
| Humacyte, Inc. | 23.49 Million USD | -2381.785% |
| Immunocore Holdings plc | 308.04 Million USD | -89.308% |
| Cocrystal Pharma, Inc. | 3.39 Million USD | -17101.917% |
| Blueprint Medicines Corporation | 722.86 Million USD | 19.328% |
| IO Biotech, Inc. | 91.44 Million USD | -537.714% |
| MEI Pharma, Inc. | 34.78 Million USD | -1576.427% |
| GT Biopharma, Inc. | 13.57 Million USD | -4195.411% |
| Cabaletta Bio, Inc. | 74.66 Million USD | -681.068% |
| Summit Therapeutics Inc. | 87.68 Million USD | -565.038% |
| Alaunos Therapeutics, Inc. | 29.46 Million USD | -1878.842% |
| Marinus Pharmaceuticals, Inc. | 160.54 Million USD | -263.24% |
| Scholar Rock Holding Corporation | 171.29 Million USD | -240.433% |
| Pulmatrix, Inc. | 22.03 Million USD | -2546.089% |
| Elicio Therapeutics, Inc. | 34.57 Million USD | -1586.609% |
| X4 Pharmaceuticals, Inc. | 107.52 Million USD | -442.349% |
| Vigil Neuroscience, Inc. | 88.86 Million USD | -556.207% |
| Acelyrin, Inc. | 422.06 Million USD | -38.165% |
| Intellia Therapeutics, Inc. | 551.56 Million USD | -5.725% |
| Cytokinetics, Incorporated | 173.61 Million USD | -235.89% |
| Vor Biopharma Inc. | 126.03 Million USD | -362.681% |
| Evogene Ltd. | 27.79 Million USD | -1998.399% |
| Replimune Group, Inc. | 234.77 Million USD | -148.387% |
| Applied Therapeutics, Inc. | 74.17 Million USD | -686.175% |
| PDS Biotechnology Corporation | 43.04 Million USD | -1254.726% |
| Hoth Therapeutics, Inc. | 7.69 Million USD | -7480.95% |
| BridgeBio Pharma, Inc. | 614.22 Million USD | 5.06% |
| AEON Biopharma, Inc. | 48.42 Million USD | -1104.124% |
| BioLineRx Ltd. | 50.8 Million USD | -1047.878% |
| Galectin Therapeutics Inc. | 38.07 Million USD | -1431.69% |
| Atai Life Sciences N.V. | 125.78 Million USD | -363.605% |
| Aerovate Therapeutics, Inc. | 81.4 Million USD | -616.315% |
| VistaGen Therapeutics, Inc. | 34.08 Million USD | -1610.855% |
| Zentalis Pharmaceuticals, Inc. | 252.55 Million USD | -130.901% |
| Sagimet Biosciences Inc. | 32.74 Million USD | -1681.139% |
| MediciNova, Inc. | 10.9 Million USD | -5249.824% |
| Praxis Precision Medicines, Inc. | 128.82 Million USD | -352.682% |
| MiMedx Group, Inc. | 229.72 Million USD | -153.843% |
| Cardio Diagnostics Holdings, Inc. | 7.25 Million USD | -7932.827% |
| Axsome Therapeutics, Inc. | 476.36 Million USD | -22.417% |
| PTC Therapeutics, Inc. | 1.31 Billion USD | 55.547% |
| Mereo BioPharma Group plc | 35.84 Million USD | -1526.988% |
| Syndax Pharmaceuticals, Inc. | 229.95 Million USD | -153.592% |
| NRx Pharmaceuticals, Inc. | 27.58 Million USD | -2014.223% |
| Dyne Therapeutics, Inc. | 242.16 Million USD | -140.808% |
| BriaCell Therapeutics Corp. | 33.33 Million USD | -1649.606% |
| Allakos Inc. | 196.05 Million USD | -197.438% |
| scPharmaceuticals Inc. | 65.17 Million USD | -794.696% |
| Fulcrum Therapeutics, Inc. | 113.46 Million USD | -413.925% |
| Corcept Therapeutics Incorporated | 368.61 Million USD | -58.2% |
| NLS Pharmaceutics AG | 11.8 Million USD | -4838.951% |
| Precigen, Inc. | 84.18 Million USD | -592.728% |
| XOMA Corporation | 46.46 Million USD | -1155.074% |
| Kezar Life Sciences, Inc. | 111.17 Million USD | -424.548% |
| Incyte Corporation | 1.19 Billion USD | 51.017% |
| Alzamend Neuro, Inc. | 9.93 Million USD | -5768.04% |
| Cara Therapeutics, Inc. | 142.46 Million USD | -309.331% |
| Aligos Therapeutics, Inc. | 103.65 Million USD | -462.577% |
| Seer, Inc. | 110.49 Million USD | -427.781% |
| Reviva Pharmaceuticals Holdings, Inc. | 24.3 Million USD | -2299.121% |
| CRISPR Therapeutics AG | 463.49 Million USD | -25.815% |
| Akero Therapeutics, Inc. | 172.87 Million USD | -237.332% |
| Eliem Therapeutics, Inc. | 37.4 Million USD | -1458.878% |
| EyeGate Pharmaceuticals, Inc. | 8.22 Million USD | -6990.069% |
| Akari Therapeutics, Plc | 16.8 Million USD | -3369.862% |
| Novavax, Inc. | 779.12 Million USD | 25.154% |
| Lexaria Bioscience Corp. | 6.72 Million USD | -8566.494% |
| UroGen Pharma Ltd. | 138.88 Million USD | -319.867% |
| Sutro Biopharma, Inc. | 243 Million USD | -139.968% |
| Entera Bio Ltd. | 8.86 Million USD | -6481.772% |
| Lisata Therapeutics, Inc. | 25.7 Million USD | -2168.341% |
| Stoke Therapeutics, Inc. | 123.55 Million USD | -371.98% |
| Chimerix, Inc. | 93.38 Million USD | -524.426% |
| Reneo Pharmaceuticals, Inc. | 83.05 Million USD | -602.136% |
| Phathom Pharmaceuticals, Inc. | 167.82 Million USD | -247.468% |
| Outlook Therapeutics, Inc. | 53.12 Million USD | -997.656% |
| Jazz Pharmaceuticals plc | 3.25 Billion USD | 82.088% |
| AnaptysBio, Inc. | 181.56 Million USD | -221.172% |
| Aprea Therapeutics, Inc. | 16.04 Million USD | -3533.723% |
| Portage Biotech Inc. | 18.19 Million USD | -3104.269% |
| Olema Pharmaceuticals, Inc. | 104.96 Million USD | -455.583% |
| PMV Pharmaceuticals, Inc. | 80.13 Million USD | -627.73% |
| OKYO Pharma Limited | 8243.57 USD | -7073837.627% |
| Qualigen Therapeutics, Inc. | 6.09 Million USD | -9466.644% |
| Cadrenal Therapeutics, Inc. Common Stock | 7.63 Million USD | -7539.945% |
| Processa Pharmaceuticals, Inc. | 11.45 Million USD | -4989.831% |
| AbCellera Biologics Inc. | 275.23 Million USD | -111.874% |
| Genprex, Inc. | 31.06 Million USD | -1777.445% |
| Neumora Therapeutics, Inc. Common Stock | 187.52 Million USD | -210.968% |
| NLS Pharmaceutics AG | 11.8 Million USD | -4838.951% |
| Virios Therapeutics, Inc. | 5.44 Million USD | -10605.961% |
| Daré Bioscience, Inc. | 33.6 Million USD | -1635.065% |
| Titan Pharmaceuticals, Inc. | 7.46 Million USD | -7715.909% |
| Bicycle Therapeutics plc | 216.92 Million USD | -168.827% |
| Revolution Medicines, Inc. Warrant | 498.76 Million USD | -16.918% |
| Protagonist Therapeutics, Inc. | 153.65 Million USD | -279.523% |
| Erasca, Inc. | 141.52 Million USD | -312.044% |
| bluebird bio, Inc. | 240.23 Million USD | -142.742% |
| Pieris Pharmaceuticals, Inc. | 72.56 Million USD | -703.606% |
| BioMarin Pharmaceutical Inc. | 1.74 Billion USD | 66.606% |
| DBV Technologies S.A. | 92.16 Million USD | -532.753% |
| Fortress Biotech, Inc. | 200.19 Million USD | -191.288% |
| Avidity Biosciences, Inc. | 245.15 Million USD | -137.865% |
| CorMedix Inc. | 48.95 Million USD | -1091.118% |
| Travere Therapeutics, Inc. | 472 Million USD | -23.547% |
| Sensei Biotherapeutics, Inc. | 37.06 Million USD | -1473.346% |
| Orchestra BioMed Holdings, Inc. | 54.08 Million USD | -978.301% |
| Spruce Biosciences, Inc. | 62.08 Million USD | -839.314% |
| Celldex Therapeutics, Inc. | 43.41 Million USD | -1243.219% |
| Cartesian Therapeutics, Inc. | 110.86 Million USD | -425.986% |
| Cogent Biosciences, Inc. | 208.13 Million USD | -180.183% |
| Onconetix, Inc. | 34.9 Million USD | -1570.547% |
| Ocuphire Pharma, Inc. | 29.6 Million USD | -1869.685% |
| Prime Medicine, Inc. | 186.63 Million USD | -212.445% |
| Adagene Inc. | 41.83 Million USD | -1294.038% |
| Inhibrx Biosciences, Inc. | 219.83 Million USD | -165.271% |
| GlycoMimetics, Inc. | 39.28 Million USD | -1384.385% |
| Maravai LifeSciences Holdings, Inc. | 171.85 Million USD | -239.334% |
| Verve Therapeutics, Inc. | 234.88 Million USD | -148.271% |
| Voyager Therapeutics, Inc. | 35.82 Million USD | -1527.896% |
| SciSparc Ltd. | 9.01 Million USD | -6371.479% |
| Revelation Biosciences, Inc. | 8.65 Million USD | -6636.371% |
| Minerva Neurosciences, Inc. | 23.08 Million USD | -2425.684% |
| Astria Therapeutics, Inc. | 83.03 Million USD | -602.33% |
| Spero Therapeutics, Inc. | 75.25 Million USD | -674.902% |
| Tevogen Bio Holdings Inc. | 2.27 Million USD | -25544.358% |
| Arcutis Biotherapeutics, Inc. | 295.72 Million USD | -97.195% |
| Marker Therapeutics, Inc. | 17.89 Million USD | -3159.157% |
| Alnylam Pharmaceuticals, Inc. | 1.8 Billion USD | 67.604% |
| Artelo Biosciences, Inc. | 10.28 Million USD | -5568.757% |
| 2seventy bio, Inc. | 289.88 Million USD | -101.163% |
| ADMA Biologics, Inc. | 66.58 Million USD | -775.777% |
| Clene Inc. | 41.07 Million USD | -1319.777% |
| Capricor Therapeutics, Inc. | 12.8 Million USD | -4453.015% |
| Boundless Bio, Inc. Common Stock | 54.79 Million USD | -964.211% |
| Recursion Pharmaceuticals, Inc. | 352.04 Million USD | -65.644% |
| Citius Pharmaceuticals, Inc. | 36.73 Million USD | -1487.566% |
| Contineum Therapeutics, Inc. Class A Common Stock | 33.72 Million USD | -1628.964% |
| Absci Corporation | 73.66 Million USD | -691.607% |
| Regeneron Pharmaceuticals, Inc. | 2.81 Billion USD | 79.287% |
| Surrozen, Inc. | 18.55 Million USD | -3043.639% |
| Caribou Biosciences, Inc. | 150.53 Million USD | -287.379% |
| Janux Therapeutics, Inc. | 81.06 Million USD | -619.381% |
| Cingulate Inc. | 22.75 Million USD | -2462.24% |
| Galmed Pharmaceuticals Ltd. | -7.49 Million USD | 7883.569% |
| Tenax Therapeutics, Inc. | 8.23 Million USD | -6982.21% |
| Jaguar Health, Inc. | 42.01 Million USD | -1287.945% |
| Terns Pharmaceuticals, Inc. | 102.55 Million USD | -468.6% |
| ACADIA Pharmaceuticals Inc. | 754.08 Million USD | 22.669% |
| Kronos Bio, Inc. | 128.11 Million USD | -355.162% |
| Innoviva, Inc. | 132.15 Million USD | -341.262% |
| Bolt Biotherapeutics, Inc. | 84.07 Million USD | -593.626% |
| Entrada Therapeutics, Inc. | 132.17 Million USD | -341.192% |
| ZyVersa Therapeutics, Inc. | 14.41 Million USD | -3946.703% |
| Soligenix, Inc. | 7.79 Million USD | -7380.773% |
| AlloVir, Inc. | 180.93 Million USD | -222.299% |
| Century Therapeutics, Inc. | 56.07 Million USD | -940.012% |
| ORIC Pharmaceuticals, Inc. | 110.78 Million USD | -426.399% |
| Kura Oncology, Inc. | 165.8 Million USD | -251.707% |
| Ocean Biomedical, Inc. | 2.48 Million USD | -23398.382% |
| Mineralys Therapeutics, Inc. | 84.65 Million USD | -588.833% |
| Eterna Therapeutics Inc. | 19.38 Million USD | -2908.538% |
| SELLAS Life Sciences Group, Inc. | 37.86 Million USD | -1439.901% |
| Heron Therapeutics, Inc. | 172.55 Million USD | -237.949% |
| SAB Biotherapeutics, Inc. | 40.31 Million USD | -1346.496% |
| Pasithea Therapeutics Corp. | 15.97 Million USD | -3549.364% |
| Entero Therapeutics, Inc. | 15.74 Million USD | -3604.495% |
| HCW Biologics Inc. | 21.02 Million USD | -2673.247% |
| C4 Therapeutics, Inc. | 159.78 Million USD | -264.951% |
| Atara Biotherapeutics, Inc. | 275.69 Million USD | -111.52% |
| Coherus BioSciences, Inc. | 301.45 Million USD | -93.446% |
| Lantern Pharma Inc. | 17.87 Million USD | -3161.881% |
| Histogen Inc. | 14.27 Million USD | -3985.938% |
| Surrozen, Inc. | 18.55 Million USD | -3043.639% |
| Eledon Pharmaceuticals, Inc. | 43 Million USD | -1256.151% |
| Kodiak Sciences Inc. | 277.32 Million USD | -110.278% |
| MoonLake Immunotherapeutics | 54.12 Million USD | -977.442% |
| Hepion Pharmaceuticals, Inc. | 48.44 Million USD | -1103.652% |
| Adverum Biotechnologies, Inc. | 127.59 Million USD | -357.042% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | -91016.406% |
| Moderna, Inc. | 6.39 Billion USD | 90.88% |
| Ionis Pharmaceuticals, Inc. | 779.58 Million USD | 25.198% |
| Turnstone Biologics Corp. | 78.33 Million USD | -644.396% |
| Immix Biopharma, Inc. | 16.14 Million USD | -3512.793% |
| Tiziana Life Sciences Ltd | 14.58 Million USD | -3897.978% |
| Aurinia Pharmaceuticals Inc. | 253.05 Million USD | -130.441% |
| Exelixis, Inc. | 1.58 Billion USD | 63.25% |
| Monte Rosa Therapeutics, Inc. | 143.31 Million USD | -306.909% |
| Wave Life Sciences Ltd. | 181.3 Million USD | -221.645% |
| Conduit Pharmaceuticals Inc. | 5.56 Million USD | -10384.448% |
| Alkermes plc | 996.24 Million USD | 41.466% |
| Jasper Therapeutics, Inc. | 68.86 Million USD | -746.844% |
| Arcellx, Inc. | 200.19 Million USD | -191.283% |
| ESSA Pharma Inc. | 32.13 Million USD | -1714.723% |
| TNF Pharmaceuticals, Inc. | 16.36 Million USD | -3464.408% |
| Avid Bioservices, Inc. | 25.99 Million USD | -2143.21% |
| Insmed Incorporated | 949.26 Million USD | 38.569% |
| Cardiff Oncology, Inc. | 45.9 Million USD | -1170.468% |
| Enanta Pharmaceuticals, Inc. | 216.41 Million USD | -169.462% |
| Moolec Science SA | 52.75 Million USD | -1005.475% |
| RenovoRx, Inc. | 11.39 Million USD | -5017.102% |
| Acumen Pharmaceuticals, Inc. | 61.13 Million USD | -853.818% |
| Geron Corporation | 70.44 Million USD | -727.849% |
| LAVA Therapeutics N.V. | 46.54 Million USD | -1152.997% |
| Verrica Pharmaceuticals Inc. | 70.59 Million USD | -726.055% |
| Royalty Pharma plc | 862.4 Million USD | 32.381% |
| OmniAb, Inc. | 83.89 Million USD | -595.089% |
| Alector, Inc. | 248.8 Million USD | -134.381% |
| Atea Pharmaceuticals, Inc. | 94.07 Million USD | -519.892% |
| Mersana Therapeutics, Inc. | 207.81 Million USD | -180.612% |
| Humacyte, Inc. | 23.49 Million USD | -2381.785% |
| Structure Therapeutics Inc. | 102.77 Million USD | -467.4% |
| Revance Therapeutics, Inc. | 398.65 Million USD | -46.278% |
| 89bio, Inc. | 151.2 Million USD | -285.668% |
| Avenue Therapeutics, Inc. | 14.54 Million USD | -3910.626% |
| Aura Biosciences, Inc. | 84.99 Million USD | -586.126% |
| Immunic, Inc. | 99.22 Million USD | -487.712% |
| Veracyte, Inc. | 357.93 Million USD | -62.92% |
| Genelux Corporation | 24.33 Million USD | -2296.322% |
| Trevi Therapeutics, Inc. | 33.92 Million USD | -1619.025% |
| Adial Pharmaceuticals, Inc. | 6.88 Million USD | -8366.166% |
| Sonnet BioTherapeutics Holdings, Inc. | 7.12 Million USD | -8083.65% |
| Immunovant, Inc. | 282.7 Million USD | -106.27% |
| Vericel Corporation | 142.04 Million USD | -310.55% |
| Fortrea Holdings Inc. | 457.3 Million USD | -27.519% |
| KalVista Pharmaceuticals, Inc. | 54.27 Million USD | -974.367% |
| XBiotech Inc. | 37.51 Million USD | -1454.639% |
| Agenus Inc. | 78.18 Million USD | -645.872% |
| Acasti Pharma Inc. | 11.3 Million USD | -5060.119% |
| Kiora Pharmaceuticals, Inc. | 12.58 Million USD | -4532.953% |
| MiNK Therapeutics, Inc. | 22.92 Million USD | -2444.14% |
| Pasithea Therapeutics Corp. | 15.97 Million USD | -3549.364% |
| Theravance Biopharma, Inc. | 110.71 Million USD | -426.703% |
| Metagenomi, Inc. Common Stock | 28.84 Million USD | -1921.65% |
| NeuroBo Pharmaceuticals, Inc. | 15.88 Million USD | -3570.811% |
| Gain Therapeutics, Inc. | 22.3 Million USD | -2514.026% |
| Tempest Therapeutics, Inc. | 29.15 Million USD | -1900.017% |
| Sol-Gel Technologies Ltd. | 30.85 Million USD | -1789.708% |
| Rhythm Pharmaceuticals, Inc. | 252.48 Million USD | -130.964% |
| United Therapeutics Corporation | 885.1 Million USD | 34.115% |
| Creative Medical Technology Holdings, Inc. | 5.53 Million USD | -10443.31% |
| BriaCell Therapeutics Corp. | 32.72 Million USD | -1681.927% |
| Lixte Biotechnology Holdings, Inc. | 5.09 Million USD | -11356.149% |
| Silo Pharma, Inc. | 3.92 Million USD | -14769.108% |
| Telomir Pharmaceuticals, Inc. Common Stock | 3.94 Million USD | -14692.945% |
| Pharming Group N.V. | 225.49 Million USD | -158.611% |
| XOMA Corporation | 46.46 Million USD | -1155.074% |
| Reviva Pharmaceuticals Holdings, Inc. | 24.3 Million USD | -2299.121% |
| Bionomics Limited | 17.89 Billion USD | 96.741% |
| Alpha Tau Medical Ltd. | -35.68 Million USD | 1734.375% |
| Pyxis Oncology, Inc. | 82.19 Million USD | -609.457% |
| uniQure N.V. | 285.08 Million USD | -104.551% |
| Xilio Therapeutics, Inc. | 79.13 Million USD | -636.918% |
| Cassava Sciences, Inc. | 105.95 Million USD | -450.36% |
| 60 Degrees Pharmaceuticals, Inc. | 4.93 Million USD | -11719.853% |
| Windtree Therapeutics, Inc. | 17.45 Million USD | -3240.465% |
| Poseida Therapeutics, Inc. | 194.2 Million USD | -200.27% |
| Pluri Inc. | 22.48 Million USD | -2494.061% |
| Anebulo Pharmaceuticals, Inc. | 8.3 Million USD | -6918.44% |
| MeiraGTx Holdings plc | 151.07 Million USD | -285.989% |
| Cidara Therapeutics, Inc. | 86.86 Million USD | -571.323% |
| ProMIS Neurosciences, Inc. | 8.45 Million USD | -6798.89% |
| CalciMedica, Inc. | 21.81 Million USD | -2572.893% |
| Sana Biotechnology, Inc. | 294.94 Million USD | -97.716% |
| Amicus Therapeutics, Inc. | 427.65 Million USD | -36.36% |
| Salarius Pharmaceuticals, Inc. | 12.89 Thousand USD | -4522507.414% |
| Alpha Tau Medical Ltd. | -35.68 Million USD | 1734.375% |
| Adlai Nortye Ltd. American Depositary Shares | 72.55 Million USD | -703.773% |
| Nutriband Inc. | 5.73 Million USD | -10069.896% |
| Protara Therapeutics, Inc. | 43.61 Million USD | -1237.09% |
| Compugen Ltd. | 43.97 Million USD | -1226.204% |
| Roivant Sciences Ltd. | 1.18 Billion USD | 50.962% |
| ProKidney Corp. | 151.52 Million USD | -284.858% |
| Protagenic Therapeutics, Inc. | 4.52 Million USD | -12781.563% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | -51297.433% |
| Tango Therapeutics, Inc. | 150.7 Million USD | -286.958% |
| Renovaro Biosciences Inc. | 81.63 Million USD | -614.294% |
| Zevra Therapeutics, Inc. | 74.12 Million USD | -686.758% |
| Benitec Biopharma Inc. | 22.38 Million USD | -2505.42% |
| GeoVax Labs, Inc. | 6.02 Million USD | -9583.299% |
| Biomea Fusion, Inc. | 126.13 Million USD | -362.318% |
| Cullinan Oncology, Inc. | 191.08 Million USD | -205.169% |
| 4D Molecular Therapeutics, Inc. | 133.59 Million USD | -336.518% |
| Kiniksa Pharmaceuticals, Ltd. | 262.04 Million USD | -122.534% |
| Nuvectis Pharma, Inc. | 22.89 Million USD | -2446.818% |
| Spyre Therapeutics, Inc. | 243.18 Million USD | -139.791% |
| Ventyx Biosciences, Inc. | 207.99 Million USD | -180.366% |
| Imunon, Inc. | 20.31 Million USD | -2771.161% |
| BioAtla, Inc. | 129.68 Million USD | -349.656% |
| Allogene Therapeutics, Inc. | 84.91 Million USD | -586.715% |
| Larimar Therapeutics, Inc. | 41.75 Million USD | -1296.487% |
| Zura Bio Limited | 62.63 Million USD | -830.976% |
| aTyr Pharma, Inc. | 12.97 Million USD | -4392.989% |
| Madrigal Pharmaceuticals, Inc. | 380.49 Million USD | -53.259% |
| Viridian Therapeutics, Inc. | 254.76 Million USD | -128.896% |
| Galecto, Inc. | 35.62 Million USD | -1536.806% |
| Tevogen Bio Holdings Inc. | 2.27 Million USD | -25544.358% |
| Halozyme Therapeutics, Inc. | 299.31 Million USD | -94.825% |
| Lexicon Pharmaceuticals, Inc. | 172.86 Million USD | -237.333% |
| PolyPid Ltd. | 21.04 Million USD | -2670.943% |
| Aileron Therapeutics, Inc. | 16.27 Million USD | -3482.852% |
| Forte Biosciences, Inc. | 32.47 Million USD | -1695.563% |
| Xencor, Inc. | 306.97 Million USD | -89.964% |
| Coeptis Therapeutics Holdings, Inc. | 20.48 Million USD | -2746.014% |
| Lexaria Bioscience Corp. | 6.72 Million USD | -8566.494% |
| Instil Bio, Inc. | 85.78 Million USD | -579.775% |
| Cardio Diagnostics Holdings, Inc. | 7.25 Million USD | -7932.827% |
| OncoCyte Corporation | 25.63 Million USD | -2174.623% |
| Elevation Oncology, Inc. | 45.44 Million USD | -1183.188% |
| Purple Biotech Ltd. | -22.46 Million USD | 2695.562% |
| CollPlant Biotechnologies Ltd. | 16.48 Million USD | -3438.501% |
| MacroGenics, Inc. | 217.21 Million USD | -168.464% |
| Verona Pharma plc | 67.15 Million USD | -768.405% |
| Tharimmune, Inc. | 9.45 Million USD | -6067.44% |
| Apogee Therapeutics, Inc. | 93 Million USD | -527.017% |
| enGene Holdings Inc. Warrants | 25.88 Million USD | -2152.83% |
| Aditxt, Inc. | 25.95 Million USD | -2147.121% |
| XTL Biopharmaceuticals Ltd. | 765 Thousand USD | -76128.105% |
| Savara Inc. | 15.74 Million USD | -3603.684% |
| Curis, Inc. | 58.35 Million USD | -899.306% |
| Carmell Therapeutics Corporation | 5.09 Million USD | -11351.082% |
| Achieve Life Sciences, Inc. | 27.02 Million USD | -2058.038% |
| BeiGene, Ltd. | 3.28 Billion USD | 82.257% |
| Protagenic Therapeutics, Inc. | 4.52 Million USD | -12781.563% |
| Vincerx Pharma, Inc. | 42.6 Million USD | -1268.596% |
| Plus Therapeutics, Inc. | 8.54 Million USD | -6725.199% |
| Acrivon Therapeutics, Inc. Common Stock | 66.7 Million USD | -774.267% |
| Rigel Pharmaceuticals, Inc. | 130.26 Million USD | -347.667% |
| Adicet Bio, Inc. | 152.03 Million USD | -283.552% |
| Estrella Immunopharma, Inc. | 7.31 Million USD | -7877.253% |
| Quantum-Si incorporated | 111.65 Million USD | -422.255% |
| Acurx Pharmaceuticals, Inc. | 14.57 Million USD | -3900.235% |
| Generation Bio Co. | 144.46 Million USD | -303.653% |
| Black Diamond Therapeutics, Inc. | 86.46 Million USD | -574.468% |
| Invivyd, Inc. | 205.75 Million USD | -183.417% |
| Relay Therapeutics, Inc. | 72.15 Million USD | -708.139% |
| Quoin Pharmaceuticals, Ltd. | 9.37 Million USD | -6117.889% |
| Moolec Science SA | 52.75 Million USD | -1005.475% |
| Clearside Biomedical, Inc. | 32.71 Million USD | -1682.5% |
| Longboard Pharmaceuticals, Inc. | 56.75 Million USD | -927.405% |
| Relmada Therapeutics, Inc. | 103.7 Million USD | -462.328% |
| ALX Oncology Holdings Inc. | 170.27 Million USD | -242.466% |
| Vir Biotechnology, Inc. | 767.72 Million USD | 24.042% |
| Evaxion Biotech A/S | 22.27 Million USD | -2518.523% |
| Ocular Therapeutix, Inc. | 135.54 Million USD | -330.226% |
| Tyra Biosciences, Inc. | 79.94 Million USD | -629.433% |
| Unity Biotechnology, Inc. | 44.66 Million USD | -1205.539% |
| Connect Biopharma Holdings Limited | 62.07 Million USD | -839.435% |
| Clearmind Medicine Inc. | 8.74 Million USD | -6571.109% |
| Aadi Bioscience, Inc. | 93.47 Million USD | -523.831% |
| Catalyst Pharmaceuticals, Inc. | 259.42 Million USD | -124.784% |
| CERo Therapeutics Holdings, Inc. | 2.93 Million USD | -19782.304% |
| Viking Therapeutics, Inc. | 100.82 Million USD | -478.362% |
| Keros Therapeutics, Inc. | 169.27 Million USD | -244.492% |
| Crinetics Pharmaceuticals, Inc. | 226.62 Million USD | -157.322% |
| ImmunityBio, Inc. | 362.87 Million USD | -60.703% |
| Korro Bio, Inc. | 84.53 Million USD | -589.835% |
| Kineta, Inc. | 21.15 Million USD | -2656.405% |
| BioVie Inc. | 31.95 Million USD | -1725.168% |
| Codexis, Inc. | 66.51 Million USD | -776.672% |
| Celularity Inc. | 215.05 Million USD | -171.157% |
| Virax Biolabs Group Limited | 6.54 Million USD | -8806.971% |
| Cibus, Inc. | 320.3 Million USD | -82.059% |
| Annexon, Inc. | 143.72 Million USD | -305.742% |
| Assembly Biosciences, Inc. | 22.9 Million USD | -2445.484% |
| Eyenovia, Inc. | 25.4 Million USD | -2195.264% |
| Puma Biotechnology, Inc. | 140.31 Million USD | -315.597% |
| NeurAxis, Inc. | 8.82 Million USD | -6510.723% |
| Regulus Therapeutics Inc. | 9.95 Million USD | -5756.634% |
| Compass Therapeutics, Inc. | 48.47 Million USD | -1103.031% |
| TFF Pharmaceuticals, Inc. | 22.62 Million USD | -2477.034% |
| Notable Labs, Ltd. | 14.77 Million USD | -3848.172% |
| IN8bio, Inc. | 30.33 Million USD | -1822.224% |
| DiaMedica Therapeutics Inc. | 21.26 Million USD | -2642.018% |
| Vera Therapeutics, Inc. | 102.01 Million USD | -471.644% |
| Lumos Pharma, Inc. | 38.66 Million USD | -1408.199% |
| Liquidia Corporation | 87.98 Million USD | -562.785% |
| Mustang Bio, Inc. | 48.5 Million USD | -1102.336% |
| Quantum-Si incorporated | 111.65 Million USD | -422.255% |
| Arbutus Biopharma Corporation | 22.54 Million USD | -2486.697% |
| enGene Holdings Inc. Common Stock | 25.88 Million USD | -2152.83% |
| ARS Pharmaceuticals, Inc. | 67.55 Million USD | -763.279% |
| 180 Life Sciences Corp. | 13.47 Million USD | -4226.804% |
| Vaxcyte, Inc. | 468.04 Million USD | -24.593% |
| Xenon Pharmaceuticals Inc. | 46.54 Million USD | -1152.944% |
| Estrella Immunopharma, Inc. | 7.31 Million USD | -7877.253% |
| NKGen Biotech, Inc. Warrants | 28.54 Million USD | -1943.04% |
| Opiant Pharmaceuticals, Inc. | 26.5 Million USD | -2100.344% |
| CERo Therapeutics Holdings, Inc. | 2.93 Million USD | -19782.304% |
| Soleno Therapeutics, Inc. | 41.38 Million USD | -1309.107% |
| PepGen Inc. | 84.76 Million USD | -587.947% |
| Moleculin Biotech, Inc. | 29.63 Million USD | -1868.023% |
| Solid Biosciences Inc. | 104.31 Million USD | -459.023% |
| Palisade Bio, Inc. | 13.32 Million USD | -4277.965% |
| Nutriband Inc. | 5.73 Million USD | -10069.896% |
| Conduit Pharmaceuticals Inc. | 5.56 Million USD | -10384.448% |
| Immuneering Corporation | 58.41 Million USD | -898.316% |
| Belite Bio, Inc | 31.66 Million USD | -1741.433% |
| CG Oncology, Inc. Common stock | 55.65 Million USD | -947.823% |
| GeoVax Labs, Inc. | 6.02 Million USD | -9583.299% |
| Tourmaline Bio, Inc. | 45.4 Million USD | -1184.206% |
| Altimmune, Inc. | 30.55 Million USD | -1808.447% |
| Peak Bio, Inc. | 1249.13 USD | -46683992.128% |
| SeaStar Medical Holding Corporation | 14.21 Million USD | -4003.765% |
| FibroBiologics, Inc. Common Stock | 8.88 Million USD | -6460.299% |
| Neurogene Inc. | 55.58 Million USD | -949.143% |
| Mirum Pharmaceuticals, Inc. | 248.48 Million USD | -134.676% |
| Kintara Therapeutics, Inc. | 8.45 Million USD | -6800.308% |
| CARGO Therapeutics, Inc. Common Stock | 96.71 Million USD | -502.983% |
| Sesen Bio, Inc. | 78.38 Million USD | -643.988% |
| argenx SE | 1.53 Billion USD | 61.974% |
| NKGen Biotech, Inc. Common Stock | 28.54 Million USD | -1943.04% |
| Dianthus Therapeutics, Inc. | 51 Million USD | -1043.422% |
| Immunome, Inc. | 122.82 Million USD | -374.796% |
| Enveric Biosciences, Inc. | 16.44 Million USD | -3445.291% |
| Design Therapeutics, Inc. | 78.19 Million USD | -645.805% |
| Seelos Therapeutics, Inc. | 12.58 Million USD | -4533.651% |
| Enliven Therapeutics, Inc. | 83.52 Million USD | -598.135% |
| Iovance Biotherapeutics, Inc. | 450.99 Million USD | -29.302% |
| Taysha Gene Therapies, Inc. | 87.89 Million USD | -563.494% |
| Inovio Pharmaceuticals, Inc. | 132.55 Million USD | -339.926% |
| Athira Pharma, Inc. | 125.46 Million USD | -364.783% |
| XOMA Corporation | 46.46 Million USD | -1155.074% |
| Merus N.V. | 200.49 Million USD | -190.854% |
| Quince Therapeutics, Inc. | 34.62 Million USD | -1584.417% |
| Rezolute, Inc. | 70.38 Million USD | -728.484% |
| Clene Inc. | 41.07 Million USD | -1319.777% |
| Indaptus Therapeutics, Inc. | 16.37 Million USD | -3460.435% |
| BeyondSpring Inc. | 24.86 Million USD | -2245.244% |
| Synlogic, Inc. | 58.53 Million USD | -896.284% |
| Allarity Therapeutics, Inc. | 17.89 Million USD | -3159.25% |
| Phio Pharmaceuticals Corp. | 4.49 Million USD | -12881.857% |
| Peak Bio, Inc. | 1249.13 USD | -46683992.128% |
| Werewolf Therapeutics, Inc. | 60.44 Million USD | -864.737% |
| Krystal Biotech, Inc. | 160.42 Million USD | -263.498% |
| Karyopharm Therapeutics Inc. | 270.63 Million USD | -115.476% |
| SpringWorks Therapeutics, Inc. | 348.03 Million USD | -67.552% |
| Lipella Pharmaceuticals Inc. | 2.15 Million USD | -26938.337% |
| MannKind Corporation | 125.59 Million USD | -364.299% |
| Ikena Oncology, Inc. | 84.57 Million USD | -589.484% |
| Cyclerion Therapeutics, Inc. | 9.64 Million USD | -5944.833% |
| Gyre Therapeutics, Inc. | 89.6 Million USD | -550.824% |
| Gossamer Bio, Inc. | 183.75 Million USD | -217.342% |
| CohBar, Inc. | 12.38 Million USD | -4607.225% |
| Cognition Therapeutics, Inc. | 50.72 Million USD | -1049.643% |
| NRx Pharmaceuticals, Inc. | 27.58 Million USD | -2014.223% |
| Mural Oncology plc | 192.07 Million USD | -203.609% |
| Disc Medicine, Inc. | 91.12 Million USD | -539.94% |
| Champions Oncology, Inc. | 28.11 Million USD | -1974.511% |
| REGENXBIO Inc. | 321.15 Million USD | -81.576% |
| Ensysce Biosciences, Inc. | 5.36 Million USD | -10777.067% |
| Anavex Life Sciences Corp. | 55.75 Million USD | -945.887% |
| Cellectar Biosciences, Inc. | 38.96 Million USD | -1396.754% |
| Edgewise Therapeutics, Inc. | 114.35 Million USD | -409.934% |
| Vaxart, Inc. | 90.72 Million USD | -542.754% |
| PharmaCyte Biotech, Inc. | 8.52 Million USD | -6744.418% |
| Aldeyra Therapeutics, Inc. | 42.79 Million USD | -1262.677% |
| Cellectis S.A. | 97.32 Million USD | -499.204% |
| Longeveron Inc. | 21.25 Million USD | -2644.212% |
| Repare Therapeutics Inc. | 167.35 Million USD | -248.444% |
| Sarepta Therapeutics, Inc. | 1.36 Billion USD | 57.147% |
| Inozyme Pharma, Inc. | 75.64 Million USD | -670.897% |
| Revolution Medicines, Inc. | 498.76 Million USD | -16.918% |
| Nymox Pharmaceutical Corporation | 6.65 Million USD | -8666.461% |
| Third Harmonic Bio, Inc. | 43.95 Million USD | -1226.717% |
| ArriVent BioPharma, Inc. Common Stock | 74.59 Million USD | -681.801% |
| AN2 Therapeutics, Inc. | 69.63 Million USD | -737.431% |
| Anixa Biosciences, Inc. | 11.06 Million USD | -5172.559% |
| Vertex Pharmaceuticals Incorporated | 4.77 Billion USD | 87.788% |
| Denali Therapeutics Inc. | 527.23 Million USD | -10.605% |
| Revelation Biosciences, Inc. | 8.65 Million USD | -6636.371% |
| Veru Inc. | 101.34 Million USD | -475.388% |
| Corvus Pharmaceuticals, Inc. | 23.4 Million USD | -2391.327% |
| Cingulate Inc. | 22.75 Million USD | -2462.24% |
| Passage Bio, Inc. | 108.38 Million USD | -438.011% |
| Context Therapeutics Inc. | 25.07 Million USD | -2225.824% |
| Exicure, Inc. | 14.07 Million USD | -4042.832% |
| Day One Biopharmaceuticals, Inc. | 206.06 Million USD | -182.992% |
| Oramed Pharmaceuticals Inc. | 43.3 Million USD | -1246.724% |
| Scinai Immunotherapeutics Ltd. | 9.17 Million USD | -6254.218% |
| Nuvalent, Inc. | 149.49 Million USD | -290.084% |
| ABVC BioPharma, Inc. | 8.06 Million USD | -7128.859% |
| Carisma Therapeutics, Inc. | 103.65 Million USD | -462.61% |
| Unicycive Therapeutics, Inc. | 21.44 Million USD | -2618.751% |
| OmniAb, Inc. | 83.89 Million USD | -595.089% |
| Anew Medical, Inc. | 1.3 Million USD | -44728.307% |
| Fennec Pharmaceuticals Inc. | 32.76 Million USD | -1679.835% |
| Lipocine Inc. | 15.08 Million USD | -3766.974% |
| Lexeo Therapeutics, Inc. Common Stock | 68.51 Million USD | -751.145% |
| Nautilus Biotechnology, Inc. | 76.15 Million USD | -665.765% |
| SAB Biotherapeutics, Inc. | 40.31 Million USD | -1346.496% |
| G1 Therapeutics, Inc. | 114.84 Million USD | -407.776% |
| Bellerophon Therapeutics, Inc. | 22.38 Million USD | -2505.187% |
| Sage Therapeutics, Inc. | 664.14 Million USD | 12.196% |
| Ocugen, Inc. | 71.56 Million USD | -714.824% |
| Mind Medicine (MindMed) Inc. | 93.86 Million USD | -521.253% |
| Q32 Bio Inc. | 92.68 Million USD | -529.203% |
| Brainstorm Cell Therapeutics Inc. | 21.17 Million USD | -2654.062% |
| Alumis Inc. Common Stock | 158.17 Million USD | -268.673% |
| Equillium, Inc. | 50.6 Million USD | -1052.324% |
| Kyverna Therapeutics, Inc. | 62.4 Million USD | -834.437% |
| Coya Therapeutics, Inc. | 13.9 Million USD | -4093.612% |
| CNS Pharmaceuticals, Inc. | 18.86 Million USD | -2991.13% |
| Dominari Holdings Inc. | 23.83 Million USD | -2346.591% |
| Edesa Biotech, Inc. | 9.22 Million USD | -6222.892% |
| vTv Therapeutics Inc. | 11.9 Million USD | -4797.497% |
| Bio-Techne Corporation | 563.03 Million USD | -3.571% |
| Agios Pharmaceuticals, Inc. | 408.8 Million USD | -42.646% |
| Harmony Biosciences Holdings, Inc. | 268.75 Million USD | -116.979% |
| Prelude Therapeutics Incorporated | 132.27 Million USD | -340.851% |
| Candel Therapeutics, Inc. | 14.41 Million USD | -3946.527% |
| iTeos Therapeutics, Inc. | 163.69 Million USD | -256.237% |
| Nkarta, Inc. | 131.65 Million USD | -342.951% |
| BioCardia, Inc. | 12.12 Million USD | -4711.03% |
| Iterum Therapeutics plc | 47.46 Million USD | -1128.501% |